Home
Market
IPO
Screener
Bundles
Super Investors
Sector
Discover
TickerPlus
Account
Paramesu Biotech
Consolidated
Standalone
Peers
P&L
Balance Sheet
Cash Flows
Corp. Action
News
Ticker
>
Company
>
Paramesu Biotech share price
Paramesu Biotech Ltd.
271
0
0
The company is currently not listed and is under IPO, so all the data might not be available.
Peer Comparison
View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.
Ratios
Sales Growth
1 Year
0.63%
3 Year
NA
5 Year
NA
Profit Growth
1 Year
24.02%
3 Year
NA
5 Year
NA
ROE%
1 Year
26.36%
3 Year
29.27%
ROCE %
1 Year
21.36%
3 Year
25.01%
Debt/Equity
1.1892
Price to Cash Flow
0
Interest Cover Ratio
0
CFO/PAT
(5 Yr. Avg.)
0
Strengths
Company has been maintaining healthy ROE of
29.2709333333333
% over the past 3 years.
Company has been maintaining healthy ROCE of
25.0139333333333
% over the past 3 years.
The company has an efficient Cash Conversion Cycle of
0
days.
Limitations
The company has shown a poor profit growth of
0
% for the Past 3 years.
The company has shown a poor revenue growth of
0
% for the Past 3 years.
Company has low Interest coverage ratio of
0
.
The company has a low EBITDA margin of
0
% over the past 5 years.
Profit & Loss
(All Figures in Cr. Adjusted EPS in Rs.)
PARTICULARS
Mar 2022
Mar 2023
Mar 2024
Net Sales
494.91
623.93
627.85
Total Expenditure
435.16
567.2
551.3
Operating Profit
59.75
56.73
76.55
Other Income
1.7
1.42
1.44
Interest
10.06
8.55
15.26
Depreciation
5.38
5.57
8.3
Exceptional Items
0
0
0
Profit Before Tax
46.01
44.02
54.43
Tax
12.04
11.5
14.09
Net Profit
33.97
32.52
40.34
Adjusted EPS (Rs.)
1.29
1.24
1.54
Balance Sheet
(All Figures are in Crores.)
Particulars
Mar 2022
Mar 2023
Mar 2024
Equity and Liabilities
Share Capital
26.26
26.26
26.26
Total Reserves
74.69
106.7
146.87
Borrowings
41.37
88.77
101.34
Other N/C liabilities
9.77
11.26
15.67
Current liabilities
86.79
86.18
149.55
Total Liabilities
238.88
319.17
439.68
Assets
Net Block
130.41
127.55
241.62
Capital WIP
2.87
65.98
23.89
Intangible WIP
0
0
0
Investments
0
0
0
Loans & Advances
2.38
2.63
3.35
Other N/C Assets
0.19
0.28
0.21
Current Assets
103.03
122.74
170.61
Total Assets
238.88
319.17
439.68
* Other Non-current Liabilities include Net deferred Liabilities
Cash Flows
(All Figures are in Crores.)
PARTICULARS
Mar 2023
Mar 2024
Profit from operations
44.02
54.43
Adjustment
13.72
23.4
Changes in Assets & Liabilities
-32.64
-34.85
Tax Paid
-9.96
-10.8
Operating Cash Flow
15.13
32.18
Investing Cash Flow
-65.41
-79.89
Financing Cash Flow
50.04
50.07
Net Cash Flow
-0.24
2.35
Corporate Actions
Dividend
Bonus
Rights
Split
Company News
Paramesu Biotech gets SEBI's nod for Rs 600 crore IPO
5 Mar, 3:03 PM
Paramesu Biotech files Rs 600 crore IPO papers with SEBI
11 Nov, 12:20 PM
Last Updated on:
Brief about Paramesu Biotech
x
Ratio Delete Confirmation
×
Are you sure you want to DELETE
from your ratio list? This will also hide it from all other companies that you analyze.
X